CNS Co.,Ltd. (4076.T) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	7.4B	7.0B	6.7B	6.0B	5.4B
Cost of Revenue	1.4B	5.3B	5.0B	4.5B	4.1B
Gross Profit	488.2M	1.7B	1.6B	1.5B	1.3B
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	305.9M	1.2B	1.0B	947.0M	788.8M
General & Admin Expense	—	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	—	—	—	—	—
Total Operating Expenses	305.9M	1.2B	1.0B	947.0M	788.8M
Cost and Expenses	6.7B	6.4B	6.0B	5.4B	4.9B
Operating Income (EBIT)	679.0M	555.0M	619.0M	559.0M	533.0M
Non-Operating
Interest Income	2.6M	1.5M	38.0K	39.0K	111.0K
Interest Expense	44.0K	220.0K	285.0K	250.0K	152.0K
Net Interest Income	2.6M	1.2M	(247.0K)	(211.0K)	(41.0K)
Other Non-Op Income/Expense	477.0K	29.9M	30.3M	28.6M	61.1M
Non-Operating Income (excl Interest)	2.0M	29.1M	32.8M	29.3M	61.3M
EBT (Pre-Tax Income)	229.0M	582.5M	636.5M	589.2M	594.7M
Income Tax Expense	74.2M	155.2M	175.2M	156.1M	185.2M
Bottom Line
Net Income	538.0M	427.0M	461.0M	433.0M	409.0M
Earnings from Cont. Ops	—	—	—	—	—
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	538.0M	427.0M	461.0M	433.0M	409.0M
Per Share
Basic EPS	¥185	¥147	¥159	¥149	¥146
Diluted EPS	¥185	—	—	—	—
Revenue Per Share	¥2,544	¥2,410	¥2,291	¥2,061	¥1,926
Shares
Basic Shares Outstanding	2.9M	2.9M	2.9M	2.9M	2.8M
Diluted Shares Outstanding	—	—	—	—	—
Profitability Metrics
EBITDA	—	601.0M	653.4M	588.8M	558.4M
D&A	—	46.0M	34.4M	29.8M	25.4M
EBIT	679.0M	555.0M	619.0M	559.0M	533.0M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Feb 1, 2026